Skip to main content

Friedreich Ataxia

Detection of GAA Repeat Expansions and Frataxin Point Mutations

  • Protocol
Congenital Heart Disease

Part of the book series: Methods in Molecular Medicine ((MIMM,volume 126))

Abstract

Friedreich ataxia (FA) is an autosomal-recessive disease primarily characterized by progressive neurological disability. A significant proportion of patients also present with a hypertrophic cardiomyopathy, which may, in some cases, cause premature death. FA is caused by insufficient levels of the protein, frataxin, which is involved in mitochondrial iron metabolism. All patients carry at least one copy of an intronic GAA triplet-repeat expansion that interferes with frataxin transcription. Normal chromosomes contain up to 35 to 40 GAA triplets in an Alu sequence localized in the first intron of the frataxin gene; FA chromosomes carry from approx 70 to more than 1000 GAA triplets. The molecular diagnosis of FA is, therefore, based on the detection of this expansion, which is present in homozygosity in more than 95% of the cases. The remaining patients are heterozygous for the GAA expansion and carry a frataxin point mutation as the other pathogenic allele. The expanded GAA triplet repeat may be detected by polymerase chain reaction (PCR) amplification followed by agarose gel electrophoresis analysis. In our hands, carefully performed PCR testing, in particular, if fragment detection is enhanced by hybridization with a GAA oligonucleotide probe, is as effective in identifying patients and carriers as is Southern blot analysis of genomic DNA, and allows a more accurate sizing of the repeat. Furthermore, in the case of smaller expansions, the amplified fragment may be directly sequenced to identify very rare nonpathogenic variant repeats, such as GAAGGA. Sequence analysis of the five coding exons of the frataxin gene should be performed in clinically affected individuals who are heterozygous for an expanded GAA repeat to identify point mutations.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Geoffroy, G., Barbeau, A., Breton, G., et al. (1976) Clinical description and roentgenologic evaluation of patients with Friedreich ataxia. Can. J. Neurol. Sci. 3, 279–286.

    CAS  Google Scholar 

  2. Harding, A. E. (1981) Friedreich ataxia: a clinical and genetic study of 90 families with an analysis of early diagnosis criteria and intrafamilial clustering of clinical features. Brain 104, 589–620.

    Article  CAS  PubMed  Google Scholar 

  3. Filla, A. De Michele, G., Caruso, G., Marconi, R., and Campanella, G. (1990) Genetic data and natural history of Friedreich disease: a study of 80 Italian patients. J. Neurol. 237, 345–351.

    Article  CAS  PubMed  Google Scholar 

  4. Muller-Felber, W., Rossmanith, T., Spes, C., Chamberlain, S., Pongratz, D., and Deufel, T. (1993) The clinical spectrum of Friedreich ataxia in German families showing linkage to the FRDA locus on chromosome 9. Clin. Investig. 71, 109–114.

    Article  CAS  PubMed  Google Scholar 

  5. Campanella, G., Filla, A. De Falco, F. Mansi, D., Durivage, A., and Barbeau, A.(1980) Friedreich ataxia in the south of Italy: A clinical and biochemical survey of 23 patients. Can. J. Neurol. Sci. 7, 351–357.

    CAS  PubMed  Google Scholar 

  6. D’Angelo, A., Di Donato, S., Negri, G., Beulche, F., Uziel, G. and Boeri, R. (1980) Friedreich ataxia in northern Italy: I. Clinical, neurophysiological and in vivo biochemical studies. Can. J. Neurol. Sci. 7, 359–365.

    CAS  Google Scholar 

  7. Ulku, A., Arac, N., and Ozeren, A. (1988) Friedreich ataxia: a clinical review of 20 childhood cases. Acta Neurol. Scand. 77, 493–497.

    CAS  PubMed  Google Scholar 

  8. De Michele, G., Di Maio, L., Filla, A., et al. (1996) Childhood onset of Friedreich ataxia: a clinical and genetic study of 36 cases. Neuropediatrics 27, 3–7

    Article  PubMed  Google Scholar 

  9. Klockgether, T., Chamberlain, S., Wullner, U., et al. (1993) Late-onset Friedreich ataxia. Molecular genetics, clinical neurophysiology, and magnetic resonance imaging. Arch. Neurol. 50, 803–806.

    CAS  PubMed  Google Scholar 

  10. De Michele, G., Filla, A., Cavalcanti, F., et al. (1994) Late onset Friedreich disease: clinical features and mapping of mutation to the FRDA locus. J. Neurol. Neurosurg. Psychiatry 57, 977–979.

    Article  PubMed  Google Scholar 

  11. Gentil, M. (1990) Dysarthria in Friedreich disease. Brain Lang. 38, 438–448.

    Article  CAS  PubMed  Google Scholar 

  12. Cisneros, E. and Braun, C. M. (1995) Vocal and respiratory diadochokinesia in Friedreich ataxia. Neuropathological correlations. Rev. Neurol. (Paris) 151, 113–123.

    CAS  Google Scholar 

  13. Beauchamp, M., Labelle, H., Duhaime, M., and Joncas, J. (1995) Natural history of muscle weakness in Friedreich’s Ataxia and its relation to loss of ambulation. Clin Orthop. 311, 270–275.

    PubMed  Google Scholar 

  14. Spieker, S., Schulz, J. B., Petersen, D., Fetter, M., Klockgether, T., and Dichgans, J. (1995) Fixation instability and oculomotor abnormalities in Friedreich ataxia. J. Neurol. 242, 517–521.

    Article  CAS  PubMed  Google Scholar 

  15. Kirkham, T. H. and Coupland, S. G. (1981) An electroretinal and visual evoked potential study in Friedreich ataxia. Can. J. Neurol. Sci. 8, 289–294.

    CAS  PubMed  Google Scholar 

  16. Livingstone, I. R., Mastaglia, F. L., Edis, R., and Howe, J. W. (1981) Visual involvement in Friedreich ataxia and hereditary spastic ataxia. A clinical and visual evoked response study. Arch. Neurol. 38, 75–79.

    CAS  PubMed  Google Scholar 

  17. Rabiah, P. K., Bateman, J. B., Demer, J. L., and Perlman, S. (1997) Ophthalmologic findings in patients with ataxia. Am. J. Ophthalmol. 123, 108–117.

    CAS  PubMed  Google Scholar 

  18. Ell, J., Prasher, D., and Rudge, P. (1984) Neuro-otological abnormalities in Friedreich ataxia. J. Neurol. Neurosurg. Psychiatry 47, 26–32.

    Article  CAS  PubMed  Google Scholar 

  19. Cassandro, E., Mosca, F., Sequino, L., De Falco, F. A., and Campanella, G. (1986) Otoneurological findings in Friedreich ataxia and other inherited neuropathies. Audiol. 25, 84–91.

    Article  CAS  Google Scholar 

  20. Montermini, L., Richter, A., Morgan, K., et al. (1997) Phenotypic variability in Friedreich ataxia: role of the associated GAA triplet repeat expansion. Ann. Neurol. 41, 675–682.

    Article  CAS  PubMed  Google Scholar 

  21. Leone, M., Rocca, W. A., Rosso, M.G., Mantel, N., Schoenberg, B. S., and Schiffer, D. (1988) Friedreich disease: survival analysis in an Italian population. Neurology 38, 1433–1438.

    CAS  PubMed  Google Scholar 

  22. Hartman, J. M. and Booth, R. W. (1960) Friedreich ataxia: a neurocardiac disease. Am. Heart J. 60, 716–720.

    Article  CAS  PubMed  Google Scholar 

  23. Boyer, S. H., Chisholm, A. W., and McKusick, V. A. (1962) Cardiac aspects of Friedreich ataxia. Circulation 25, 493–505.

    PubMed  Google Scholar 

  24. Harding, A. E. and Hewer, R. L. (1983) The heart disease of Friedreich ataxia. A clinical and electrocardiographic changes in 30 cases. Q. J. Med. 52, 489–502.

    CAS  PubMed  Google Scholar 

  25. Pentland, B. and Fox, K. A. (1983) The heart in Friedreich ataxia. J. Neurol. Neurosurg. Psychiatry 46, 1138–1142.

    Article  CAS  PubMed  Google Scholar 

  26. Child, J. S., Perloff, J. K., Bach, P. M., Wolfe, A. D., Perlman, S., and Kark, R. A.(1986) Cardiac involvement in Friedreich ataxia: a clinical study of 75 patients. J. Am. Coll. Cardiol. 7, 1370–1378.

    Article  CAS  PubMed  Google Scholar 

  27. Alboliras, E. T., Shub, C., Gomez, M. R., et al. (1986) Spectrum of cardiac involvement in Friedreich ataxia: clinical, electrocardiographic and echocardiographic observations. Am. J. Cardiol. 58, 518–524.

    Article  CAS  PubMed  Google Scholar 

  28. Maione, S., Giunta, A., Filla, A., et al. (1997) May age onset be relevant in the occurrence of left ventricular hypertrophy in Friedreich ataxia? Clin. Cardiol. 20, 141–145.

    Article  CAS  PubMed  Google Scholar 

  29. Finocchiaro, G., Baio, G., Micossi, P., Pozza, G., and Di Donato, S. (1988) Glucose metabolism alterations in Friedreich ataxia. Neurology 38, 1292–1296.

    CAS  PubMed  Google Scholar 

  30. Schoenle, E. J., Boltshauser, E. J., Baekkeskov, S., Landin Olsson, M., Torresani, T., and von Felten, A.(1989) Preclinical and manifest diabetes mellitus in young patients with Friedreich ataxia: no evidence of immune process behind the islet cell destruction. Diabetologia 32, 378–381.

    Article  CAS  PubMed  Google Scholar 

  31. Fantus, I. G., Seni, M. H., and Andermann, E. (1993) Evidence for abnormal regulation of insulin receptors in Friedreich ataxia. J. Clin. Endocrinol. Metab. 76,60–63.

    Article  CAS  PubMed  Google Scholar 

  32. Margalith, D., Dunn, H. G., Carter, J. E., and Wright, J. M. (1984) Friedreich ataxia with dysautonomia and labile hypertension. Can. J. Neurol. Sci. 11, 73–77.

    CAS  PubMed  Google Scholar 

  33. Pousset, F., Kalotka, H., Durr, A., et al. (1996) Parasympathetic activity in Friedrich’s ataxia. Am. J. Cardiol. 78, 847–850.

    Article  CAS  PubMed  Google Scholar 

  34. McLeod, J. G. (1971) An electrophysiological and pathological study of peripheralnerves in Friedreich ataxia. J. Neurol. Sci. 12, 333–349.

    Article  CAS  PubMed  Google Scholar 

  35. Peyronnard, J. M., Bouchard, J. P., and Lapointe, M. (1976) Nerve conduction studies and electromyography in Friedreich ataxia. Can. J. Neurol. Sci. 3, 313–317.

    CAS  PubMed  Google Scholar 

  36. Ackroyd, R.S., Finnegan, J.A., and Green, S.H. (1984) Friedreich ataxia. A clinical review with neurophysiological and echocardiographic findings. Arch. Dis. Child. 59, 217–221.

    Article  CAS  PubMed  Google Scholar 

  37. Wullner, U., Klockgether, T., Petersen, D., Naegele, T., and Dichgans, J. (1993) Magnetic resonance imaging in hereditary and idiopathic ataxia [see comments]. Neurology 43, 318–325.

    CAS  PubMed  Google Scholar 

  38. Morvan, D., Komajda, M., Doan, L. D., et al. (1992) Cardiomyopathy in Friedreich ataxia: a Doppler-echocardiographic study. Eur. Heart J. 13, 1393–1398.

    CAS  PubMed  Google Scholar 

  39. Chamberlain, S., Shaw, J., and Rowland, A. (1998) Mapping of mutation causing Friedreich’s ataxia to human chromosome 9. Nature 334, 248–250.

    Article  Google Scholar 

  40. Campuzano, V., Montermini, L., Moltö, M. D., et al. (1996) Friedreich ataxia:autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 271, 1423–1427.

    Article  CAS  PubMed  Google Scholar 

  41. Koutnikova, H., Campuzano, V., Foury, F., Dollé, P., Cazzalini, O., and Koenig, M. (1997) Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin. Nat. Genet. 16, 345–351.

    Article  CAS  PubMed  Google Scholar 

  42. Jiralerspong, S., Liu, Y., Montermini, L., Stifani, S., and Pandolfo, M. (1997) Frataxin shows developmentally regulated tissue-specific expression in the mouse embryo. Neurobiol. Dis. 4, 103–113.

    Article  CAS  PubMed  Google Scholar 

  43. Campuzano, V., Montermini, L., Lutz, Y., et al. (1997) Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. Hum.Mol. Genet. 6, 1771–1780.

    Article  CAS  PubMed  Google Scholar 

  44. Dürr, A. Cossée, M., Agid, Y., et al. (1996) Clinical and genetic abnormalities in patients with Friedreich ataxia. N. Engl. J. Med. 335, 1169–1175.

    Article  PubMed  Google Scholar 

  45. Ohshima, K., Montermini, L., Wells, R. D., and Pandolfo, M. (1998) Inhibitory effects of expanded GAA•TTC triplet repeats from intron I of the Friedreich ataxia gene on transcription and replication in vivo. J. Biol. Chem. 273, 14,588–15,595.

    Article  CAS  PubMed  Google Scholar 

  46. Sakamoto, N. K., Ohshima, K. L., Montermini, L. M., Pandolfo, M., and Wells, R. D. (2001) Sticky DNA, a self-associated complex formed at long GAA•TTC repeats in intron 1 of the Frataxin gene, inhibits transcription. J. Biol. Chem. 276,27,171–27,177.

    Article  CAS  PubMed  Google Scholar 

  47. Sakamoto, N., Chastain, P. D., Parniewski, P., et al. (1999) Sticky DNA: selfassociation properties of long GAA•TTC repeats in R•R•Y triplex structures fromFriedreich ataxia. Mol. Cell 3, 465–475.

    Article  CAS  PubMed  Google Scholar 

  48. Cossée, M., Dürr, A., Schmitt, M., et al. (1999) Frataxin point mutations and clinicalpresentation of compound heterozygous Friedreich ataxia patients. Ann.Neurol. 45, 200–206.

    Article  PubMed  Google Scholar 

  49. Dhe-Paganon, S., Shigeta, R., Chi, Y. I., Ristow, M., and Shoelson, S. E. (2000) Crystal structure of human frataxin. J. Biol. Chem. 275, 30,753–30,756.

    Article  CAS  PubMed  Google Scholar 

  50. Musco, G., Stier, G., Kolmerer, B., et al. (2000) Towards a structural understanding of Friedreich ataxia: the solution structure of frataxin. Structure Fold. Des. 8,695–707.

    Article  CAS  PubMed  Google Scholar 

  51. Cho, S. J., Lee, M. G., Yang, J. K., Lee, J. Y., Song, H. K., and Suh, S. W. (2000) Crystal structure of Escherichia coli CyaY protein reveals a previously unidentified fold for the evolutionarily conserved frataxin family. Proc. Natl. Acad. Sci USA 97, 8932–8937.

    Article  CAS  PubMed  Google Scholar 

  52. Babcock, M., de Silva, D., Oaks, R., et al. (1997) Regulation of mitochondrial iron accumulation by Yfh1, a putative homolog of frataxin. Science 276, 1709–1712.

    Article  CAS  PubMed  Google Scholar 

  53. Wilson, R. B. and Roof, D. M. (1997) Respiratory deficiency due to loss of mitochondrial DNA in yeast lacking the frataxin homologue. Nat. Genet. 16, 352–357.

    Article  CAS  PubMed  Google Scholar 

  54. Radisky, D. C., Babcock, M. C., and Kaplan, J. (1999) The yeast frataxin homologue mediates mitochondrial iron efflux. Evidence for a mitochondrial iron cycle. J. Biol. Chem. 274, 4497–4499.

    Article  CAS  PubMed  Google Scholar 

  55. Rötig, A., deLonlay, P., Chretien, D., et al. (1997) Frataxin gene expansion causes aconitase and mitochondrial iron-sulfur protein deficiency in Friedreich ataxia. Nat. Genet. 17, 215–217.

    Article  PubMed  Google Scholar 

  56. Gardner, P. R., Rainieri, I., Epstein, L. B., and White, C. W. (1995) Superoxide radical and iron modulate aconitase activity in mammalian cells. J. Biol. Chem. 270, 13,399–13,405.

    Article  CAS  PubMed  Google Scholar 

  57. Muhlenhoff, U., Gerber, J., Richhardt, N., and Lill, R. (2003) Components involved in assembly and dislocation of iron-sulfur clusters on the scaffold protein Isu1p. EMBO J. 22, 4815–4825.

    Article  PubMed  Google Scholar 

  58. Yoon, T. and Cowan, J. A. (2003) Iron-sulfur cluster biosynthesis. Characterization of frataxin as an iron donor for assembly of [2Fe-2S] clusters in ISU-type proteins. J. Am. Chem. Soc. 125, 6078–6084.

    Article  CAS  PubMed  Google Scholar 

  59. Yoon, T. and Cowan, J. A. (2004) Frataxin-mediated iron delivery to ferrochelatase in the final step of heme biosynthesis. J. Biol. Chem. 279, 25,943–25,946.

    Article  CAS  PubMed  Google Scholar 

  60. Bulteau, A. L., O’Neill, H. A., Kennedy, M. C., Ikeda-Saito, M., Isaya, G., and Szweda, L. I. (2004) Frataxin acts as an iron chaperone protein to modulate mitochondrial aconitase activity. Science 305, 242–245.

    Article  CAS  PubMed  Google Scholar 

  61. Pandolfo, M. (2002) Iron metabolism and mitochondrial abnormalities in Friedreich ataxia. Bl. Cells Mol. Dis. 29, 536–547.

    Article  CAS  Google Scholar 

  62. Adamec, J., Rusnak, F., Owen, W. G., et al. (2000) Iron-dependent self-assembly of recombinant yeast frataxin: implications for Friedreich ataxia. Am. J. Hum. Genet. 67, 549–562.

    Article  CAS  PubMed  Google Scholar 

  63. Park, S., Gakh, O., O’Neill, H. A., et al. (2003) Yeast frataxin sequentially chaper-ones and stores iron by coupling protein assembly with iron oxidation. J. Biol. Chem. 278, 31,340–31,345.

    Article  CAS  PubMed  Google Scholar 

  64. Lamarche, J. B., Côté, M., and Lemieux, B. (1980) The cardiomyopathy of Friedreich ataxia morphological observations in 3 cases. Can. J. Neurol. Sci. 7, 389–396.

    CAS  PubMed  Google Scholar 

  65. Emond, M., Lepage, G., Vanasse, M., and Pandolfo, M. (2000) Increased levels of plasma malondialdehyde in Friedreich ataxia. Neurology 55, 1752–1753.

    CAS  PubMed  Google Scholar 

  66. Schulz, J. B., Dehmer, T., Schols, L., et al. (2000) Oxidative stress in patients with Friedreich ataxia. Neurology 55, 1719–1721.

    CAS  PubMed  Google Scholar 

  67. Santos, M., Ohshima, K., and Pandolfo, M. (2001) Frataxin deficiency enhances apoptosis in cells differentiating into neuroectoderm. Hum. Mol. Genet. 10, 1935–1944.

    Article  CAS  PubMed  Google Scholar 

  68. Wong, A., Yang, J., Cavadini, P., et al. (1999) The Friedreich ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis. Hum. Mol. Genet. 8, 425–430.

    Article  CAS  PubMed  Google Scholar 

  69. Jiralerspong, S., Ge, B., Hudson, T. J., and Pandolfo, M. (2001) Manganese super-oxide dismutase induction by iron is impaired in Friedreich ataxia cells. FEBS Lett. 509, 101–105.

    Article  CAS  PubMed  Google Scholar 

  70. Lodi, R., Cooper, J. M., Bradley, J. L., et al. (1999) Deficit of in vivo mitochon-drial ATP production in patients with Friedreich ataxia. Proc. Natl. Acad. Sci.USA 96, 11,492–11,495.

    Article  CAS  PubMed  Google Scholar 

  71. Cossée, M., Puccio, H., Gansmuller, A., et al. (2000) Inactivation of the Friedreich ataxia mouse gene leads to early embryonic lethality without iron accumulation. Hum. Mol. Genet. 9, 1219–1226.

    Article  PubMed  Google Scholar 

  72. Puccio, H., Simon, D., Cossee, M., et al. (2001) Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency fol-lowed by intramitochondrial iron deposits. Nat. Genet. 27, 181–186.

    Article  CAS  PubMed  Google Scholar 

  73. Miranda, C. J., Santos, M. M., Ohshima, K., et al. (2002) Frataxin knockin mouse. FEBS Lett. 512, 291–297.

    Article  CAS  PubMed  Google Scholar 

  74. Simon, D., Seznec, H., and Gansmuller, A. (2004) Friedreich ataxia mouse models with progressive cerebellar and sensory ataxia reveal autophagic neurodegeneration in dorsal root ganglia. J. Neurosci. 24, 1987–1995.

    Article  CAS  PubMed  Google Scholar 

  75. Schols, L., Vorgerd, M., Schillings, M., Skipka, G., and Zange, J. (2001) Idebenone in patients with Friedreich ataxia. Neurosci. Lett. 306(3), 169–172.

    Article  CAS  PubMed  Google Scholar 

  76. Hausse, A. O., Aggoun, Y., Bonnet, D., et al. (2002) Idebenone and reduced cardiac hypertrophy in Friedreich’s ataxia. Heart 87(4), 346–349.

    Article  CAS  PubMed  Google Scholar 

  77. Mariotti, C., Solari, A., Torta, D., Marano, L., Fiorentini, C., and Di Donato, S.(2003) Idebenone treatment in Friedreich patients: one-year-long randomized pla-cebo-controlled trial. Neurol. 60(10), 1676–1679.

    CAS  Google Scholar 

  78. Buyse, G., Mertens, L., Di Salvo, G., et al. (2003) Idebenone treatment in Friedreich’s ataxia: neurological, cardiac, and biochemical monitoring. Neurol. 60(10), 1679–1681.

    CAS  Google Scholar 

  79. Seznec, H., Simon, D., Monassier, L., et al. (2004) Idebenone delays the onset of cardiac functional alteration without correction of Fe-S enzymes deficit in a mouse model for Friedreich ataxia. Hum. Mol. Genet. 13(10), 1017–1024.

    Article  CAS  PubMed  Google Scholar 

  80. Lodi, R., Hart, P. E., Rajagopalan, B., et al. (2001) Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich’s ataxia. Ann. Neurol. 49, 590–596.

    Article  CAS  PubMed  Google Scholar 

  81. Schols, L., Vorgerd, M., Schillings, M., Skipka, G., and Zange, J. (2001) Idebenone in patients with Friedreich ataxia. Neurosci. Lett. 306, 169–172.

    Article  CAS  PubMed  Google Scholar 

  82. Hausse, A.O., Aggoun, Y., Bonnet, D., et al. (2002) Idebenone and reduced cardiac hypertrophy in Friedreich’s ataxia. Heart 87, 346–349.

    Article  CAS  PubMed  Google Scholar 

  83. Mariotti, C., Solari, A., Torta, D., Marano, L., Fiorentini, C., and Di Donato, S.(2003) Idebenone treatment in Friedreich patients: one-year-long randomized placebo-controlled trial. Neurol. 60, 1676–1679.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Humana Press Inc.

About this protocol

Cite this protocol

Pandolfo, M. (2006). Friedreich Ataxia. In: Kearns-Jonker, M. (eds) Congenital Heart Disease. Methods in Molecular Medicine, vol 126. Humana Press. https://doi.org/10.1385/1-59745-088-X:197

Download citation

  • DOI: https://doi.org/10.1385/1-59745-088-X:197

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-375-6

  • Online ISBN: 978-1-59745-088-1

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics